Cande, Charie M.
HRN: 15-38-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2025
CEFUROXIME 500MG (TAB)
05/16/2025
05/22/2025
PO
500mg
BId
Thinly Msaf
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes